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Vitamin B12 or cobalamin is an essential metabolite for humans, which makes it an
interesting compound for many research groups that focus in different producer-strains
synthesis pathways. In this work, we report the influence of key intermediaries for
cobalamin synthesis added to the culture medium in two Lactobacillus (L.) strains,
L. reuteri CRL 1098 and L. coryniformis CRL 1001. Here, we report that addition of
Co2+ and 5,6-dimethylbenzimidazole increased the corrinoid compounds production
in both strains while addition of L-threonine increased only the corrinoid compounds
production by CRL 1001 strain. Then, we purified and characterized by LC-MS the
corrinoid compounds obtained. Physiological studies besides in silico analysis revealed
that L. reuteri CRL 1098 and L. coryniformis CRL 1001 follow different pathways for the
last steps of the corrinoid compounds synthesis.
Keywords: lactic acid bacteria, Lactobacillus, corrinoid synthesis, cobalamin gene cluster, biosynthetic
intermediaries
INTRODUCTION
Vitamin B12 belongs to group B vitamins and is the most complex water-soluble vitamin. Many
analogous of vitamin B12 have been described; all of them are porphyrin compounds with a
common structure: a corrinoid ring contracted with a chelated cobalt ion at the center of the
macrocycle. In this vitamin, the cobalt ion is covalently bound to an upper or β-ligand, and is
coordinated with a lower or α-ligand (Rucker et al., 2001). In nature, the vitamin B12 analogs
present either an adenosyl group or a methyl group as β-ligand. The best-studied vitamin B12 is
cobalamin, a cobamide where 5,6-dimethylbenzimidazole (DMB) is the α-ligand aglycon (Johnson
and Escalante-Semerena, 1992). In the vitamin B12 synthetic preparations, the cyano group is
present as β-ligand in contrast to naturally occurring analogs. Furthermore, changes in the α-ligand
result in different vitamin B12 analogs. Several vitamin B12 analogs containing benzimidazoles,
purines, and phenolic compounds as bases of the α-ligand have been described (Chan et al., 2015).
De novo biosynthesis of all these corrinoid compounds can be divided into three main steps: (i)
the Uroporphyrinogen III synthesis; (ii) the corrinoid ring synthesis, and (iii) the adenosylation,
the amino-propanol arm attachment and the nucleotide loop bridging assembly of the lower ligand
to the cobalt of the corrinoid ring core (Martens et al., 2002). Corrinoid ring synthesis follows two
different pathways according to oxygen requirements. In the aerobic pathway, the cobalt chelation
occurs as one of the final steps of the corrinoid ring formation while in the anaerobic pathway this
reaction takes place in the first step of the synthesis (Warren et al., 2002).
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Animals cannot synthesize vitamin B12, which is involved in
many important enzymatic reactions, thus making it an essential
metabolite. These reactions are the conversion of homocysteine
to methionine and the interconversion of (2R)-methylmalonyl-
CoA to succinyl-CoA. Certain bacteria strains and archaea are
able to synthetize vitamin B12 by de novo biosynthetic pathway
(Roth et al., 1996). For this reason, many research studies are
focused on the production of vitamins by bacteria in food and
on improving the synthesis in large-scale production as well.
Currently, there are several Lactobacillus (L.) strains described
as vitamin B12 producers, such as L. reuteri CRL 1098, L. rossiae
DSM 15814, L. coryniformis CRL 1001 and L. plantarum BCF 20,
BHM 10 and LZ 95 (Taranto et al., 2003; De Angelis et al., 2014;
Torres et al., 2016; Bhushan et al., 2017) whose genomes have
been partially sequenced.
Previous genome analysis of L. reuteri CRL 1098 and
L. coryniformis CRL 1001 showed that both strains contain all
necessary genes for de novo corrinoid compound biosynthesis.
In this work, we put in evidence key differences in the last
steps of the biosynthetic pathway of these strains. Besides,
an increased corrinoid compounds synthesis was observed
when adding certain intermediaries to the culture medium.
These results were confirmed by HPLC quantification, and
compounds were characterized by mass spectrometry. The
expression profile of key genes of the biosynthetic pathway
was also studied. Finally, we demonstrated the existence of
two different biosynthetic pathways of cobalamin-type corrinoid
compounds in Lactobacillus strains.
MATERIALS AND METHODS
Strains, Media, and Culture Conditions
Lactobacillus reuteri CRL 1098 and L. coryniformis CRL
1001 were previously described as cobalamin producer strains
(Taranto et al., 2003; Torres et al., 2016). These strains belong
to CERELA-CONICET culture collection. The strains CRL 1098
and CRL 1001 were grown overnight without shaking in Man-
Rogosa-Sharpe (MRS) broth and in Vitamin B12 Assay Medium
(Merck, Germany), at 37◦C.
Salmonella (S.) Typhimurium AR 2680 was used as indicator
strain in the bioassays for cobalamin determination in minimal A
medium (NaCl, 0.5 g/l, Na2HPO4, 6 g/l; KH2PO4, 3 g/l, NH4Cl
1 g/l; glucose, 4 g/l; MgSO4, 2 mM, CaCl2 0.1 mM). This strain
has two mutations in metE and cbiB genes. The AR 2680 strain
was grown with aeration in Luria-Bertani (LB) broth at 37◦C. As
negative control, L. plantarum ATCC 8014 strain was used.
Cultures and Cell-Extracts
The biosynthetic intermediaries added to the Vitamin B12 Assay
Medium were: 5-aminolevulinic acid [ALA; final concentration
(FC): 25 ng/ml]; Cobalt Chloride (CoCl2, FC: 250 ng/ml), 5,6-
dimethylbenzimidazole (DMB; FC: 200 ng/ml); Porphobilinogen
(PBG, FC: 250 ng/ml); L-threonine (L-Thr, FC: 50 µg/ml) and
Uroporphyrinogen III (UIII, FC: 250 ng/ml). The corrinoids
produced in the presence of different intermediaries were
extracted as described by Torres et al. (2016).
Cobalamin Detection
The production of corrinoid compounds in the cell extract (CE)
obtained from each strain grown for 16 h was analyzed with
the bioassay using S. Typhimurium AR 2680 as indicator strain.
L. plantarum ATCC 8014 and a commercial cyanocobalamin
solution (0.5 µg/ml) were used as negative and positive
control, respectively. In addition, the concentration of vitamin
B12 was determined by commercial enzyme immunoassay
(RIDASCREEN-FAST Vitamin B12. R-Biopharm, Rhone Ltd.,
Glasgow, Scotland). The competitive immunoassay for the
vitamin B12 determination was performed following the protocol
described by the manufacturer.
Purification, Characterization, and
Quantification of the Corrinoid Produced
by Lactobacillus Strains
Based on previous results of our research group, key
intermediaries (alone or in combination) were added to the
growth culture media in order to increase the corrinoid
concentration produced. The following conditions were used for
L. coryniformis CRL 1001 and L. reuteri CRL 1098: (i) CoCl2, (ii)
CoCl2 plus DMB, and (iii) CoCl2 plus L-Thr only for CRL 1001
strain.
Then, the cells were broken and the corrinoid in the
intracellular fraction (cell extract -CE-) was evinced by bioassay.
The corrinoid produced was purified and quantified by RP-
HPLC. The corrinoid concentration was calculated from the
peaks areas and a commercial CN-Cbl standard curve made
with 0.5, 1, and 2 µg/ml. The peaks of the chromatogram were
collected for the mass spectrometry analysis. RP-HPLC and mass
spectrometry were carried out as described by Torres et al. (2016).
Experiments were performed three times in duplicate and results
were expressed as means± SD. Statistical analysis was conducted
using MINITAB software (version 15 for Windows). Tukey’s
post hoc test was used to test for differences between the mean
values. Significance was set at P < 0.05.
Relative Expression of Key Genes of
Cobalamin Synthesis in Lactobacillus
Strains
The primers for relative gene expression analysis (RT-qPCR) were
designed on the basis of the corresponding gene sequences of
L. coryniformis CRL 1001 (NZ_LNUL00000000.1) and L. reuteri
CRL 1098 (NZ_LYWI00000000.1) using Primer Design tool (Bio-
Rad) (Table 1). As normalizing reporter, 16S rRNA gene was
used.
Total RNA from L. coryniformis CRL 1001 and L. reuteri
CRL 1098 grown in presence of the intermediaries were
extracted at different growth phases (lag, exponential, and late
exponential). Briefly, 10 mL of the cell pellet was suspended
in 500 µL TE buffer (Tris–HCl 10 mM pH 8 – EDTA
1 nM pH 8) and added to 170 µL macaloid 2%, 500 µL
TE buffer saturated with phenol-chloroform-isoamylic solution
(chloroform-isoamylic 24:1, phenol-chloroform-isoamylic 1:1),
50 µL SDS 10% and 0,6 g glass beads (Sigma-Aldrich, Buenos
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TABLE 1 | Primer sequences of key genes of de novo biosynthesis of cobalamin-type corrinoid compounds.
Strain Gene Forward primer (5′–3′) Reverse primer (5′–3′) Amplicon length (bp)
CRL 1098 16S rRNA ACGTGCTACAATGGACGGTA ACTAGCGATTCCGACTTCGT 120
cbiF TGCGTTCCTGGTGTTAGTTC GTCCTGCCATACGCGTAATAA 106
hemB CGCGAAGTAGCTAGTGATGAA CAACTAACGGCAGCAAAGTATG 115
cobS AAGCACATGGCGAATTATTG TTCGTGACCTTTCGTCGAT 132
cobT AAACAGCAGCAGAAGTTGTTGGGC CATTGCTCCAGCCATTGCACCTAA 182
CRL 1001 16S rRNA GACGAAAGTCTGATGGAGCA TTCTGGTTGGATACCGTCAA 122
cbiF AGTGTTTCTGGGACTTTGGC CGGTATTCATGGGTGAAATG 146
hemB GATGGTATCGTGCAACAAGC ACGACACCACAATGACCAGT 113
cobS TCTTCACGAACACCCGATAA TTGCAATGGTGTTACCTGCT 141
pduX GTACGGCAGATCTAGTGGCA GCATCGATCACAGTCAATCC 148
cblS TCAGTCGGTGTAACCGTGAT GTCGCACTTCTTGGTAAGCA 148
cblT CAATTATGCATCAAGCCGTT TGGTAAGGCCACGTAGACAA 98
Aires, Argentina). This suspension was subjected to Mini-
BeadBeater-8 cell disrupter (BioSpec Products Inc.) at maximum
speed in 10 cycles of 1 min each cycle, with intervals of 1 min on
ice, to disrupt the cells. Subsequently, samples were centrifuged
(5,000 × g, 15 min, 4◦C). The upper phase was separated
and added phenol-chloroform-isoamylic solution (chloroform-
isoamylic 24:1, phenol-chloroform-isoamylic 1:1). Again, the
samples were centrifuged (5,000 × g, 15 min, 4◦C). After
separating the upper phase, RNA precipitation was done with
absolute ethanol and 3 M sodium acetate at −70◦C overnight.
Next day, samples were centrifuged (10,000 × g, 15 min, 4◦C),
washed with ethanol 70◦, and dried at room temperature. RNA
samples were suspended in 20 µL miliQ water. DNase treatment
was performed adding 10 µL of DNase (Turbo Dnase, Ambion,
Thermo Fisher Scientific, Buenos Aires, Argentina) followed
by incubation at 37◦C for 180 min. DNase was inactivated by
adding 1 µl of RQ1 DNase Stop Solution (Ambion) to the
reaction mixture and heating at 65◦C for 10 min. After verifying
the absence of DNA by conventional PCR using the purified
RNA as template, the samples were quantified with a Qubit R©2.0
fluorometer (InvitrogenTM, Life Technologies Co., Carlsbad,
CA, United States) using Qubit R©HS RNA Assay Kit (Molecular
ProbesTM, Life Technologies Co.). All RNA samples were stored
at−70◦C until use.
The cDNA was synthetized using 1 µg of total RNA and
qScriptTM cDNA SuperMix kit (Quanta BiosciencesTM) according
to the manufacturer’s instructions in a T100TM Thermal Cycler
(Bio-Rad). A conventional PCR was performed to confirm cDNA
synthesis. The cDNA was stored at −70◦C until use.
Quantitative PCR assays was performed using an iQTM5
Multicolor Real-Time PCR Detection System iCycler (Bio-Rad
Laboratories Inc.). Amplicons were detected with PerfeCtaTM
SYBER R© Green SuperMix for iQTM (Quanta BiosciencesTM).
Each reaction contained 1X SYBER R© Green SuperMix, 300 nM of
each primer and 50 ng of total cDNA, genomic DNA as positive
control and no template as negative control. All reactions were
done in duplicate. The amplification program consisted of 1 cycle
of 94◦C for 5 min and 40 cycles of amplification (94◦C for 1 min,
55◦C for 1 min, and 72◦C for 30 s) followed by a melting curve
(81 cycles of 10 s at 60◦C). The relative expression of the cbiF,
hemB, cobS, pduX, cblS, and cblT genes for L. coryniformis CRL
1001 and cbiF, hemB, cobS, and cobT for L. reuteri CRL 1098
with the addition of different synthesis intermediaries at 3, 6, and
9 h was estimated according to the 2−11CT method (Livak and
Schmittgen, 2001). The condition with the addition of CoCl2 at
3, 6, and 9 h was used as control for each point of the growth
curve for each condition. The reported values are the changes in
the gene expression of the strain grown with the intermediaries
and without (control, given value = 1) and normalized against
16S rRNA gene expression.
RESULTS
In silico Comparative Genomic Analysis
of Cobalamin Biosynthetic Gene Cluster
Lactobacillus reuteri CRL 1098 and L. coryniformis CRL 1001 are
well-known cobalamin producer strains and they have gained
attention for novel functional foods development. Previous
in silico analyses of genome sequences of both strains revealed
the presence of all the necessary genes for the de novo synthesis
of cobalamin-type compounds although some differences in the
cobalamin biosynthetic gene cluster were evidenced (Figure 1A).
The genes hemALBCD encoding proteins involved in the first
steps, the synthesis of uroporphyrinogen III from L-glutamyl-
tRNA(glu), are present in both genomes. In addition, both strains
produce the corrinoid ring by the anaerobic pathway and they
bear all the cbi genes necessary for the complete ring formation.
However, the last biosynthetic steps showed genes involved in
different pathways for the aminopropanol arm formation and the
assembly of the lower ligand.
The genome of L. reuteri CRL 1098 possesses cobT gene
encoding for a nicotinate mononucleotide (NaMN): base
phosphoribosyltransferase, which activates the lower ligand
base. In contrast, L. coryniformis CRL 1001 does not own
cobT gene but possesses the cblTS genes encoding for an
α-ribasol transporter and a kinase protein, respectively, as
described for other Firmicutes strains. The α-ribazole salvaging
and α-ribazole-P synthesis were reported previously and
presented as an alternative pathway of lower ligand activation
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FIGURE 1 | (A) cbi-cob-hem gene clusters of L. coryniformis CRL 1001 and L. reuteri CRL 1098. (B) Simplified cobalamin anaerobic synthesis pathway. Addition of
different pathway intermediaries are highlighted with a box.
(Gray and Escalante-Semerena, 2010). It is important to note that
only L. coryniformis CRL 1001 harbors the pduX gene that
encodes a kinase able to phosphorylate L-Thr. This compound
is a precursor of the aminopropanol arm that binds the lower
ligand to the corrinoid (Figure 2). The in silico studies point
out differences in the set of genes involved in the cobalamin-
type compounds synthesis. On this basis, the production of these
compounds by the strains under study in the presence of different
intermediaries was analyzed.
Effect of Biosynthetic Pathway
Intermediaries on Corrinoid Compounds
Production
Lactobacillus coryniformis CRL 1001 and L. reuteri CRL 1098
were grown in vitamin B12-free culture medium in the presence
of the following biosynthetic pathway intermediaries: ALA,
PBG, UIII, CoCl2, DMB plus CoCl2, L-Thr plus CoCl2. The
sequential addition and roles of intermediaries have been shown
in Figure 1B. The effect of DMB and L-Thr was evaluated in the
presence of supplementary CoCl2 considering that the addition
of this ion is an essential condition for the synthesis of corrinoids
in stages subsequent to the insertion of this element. The Figure 3
show the relative quantification using a commercial enzyme
immunoassay of total corrinoids in the presence of different
intermediaries respect to the condition without intermediaries.
The corrinoid production by L. coryniformis CRL 1001 was
greater with the CoCl2, DMB + CoCl2 and L-Thr + CoCl2
compared with the condition without intermediaries; ALA, PBG,
and UIII did not improve the corrinoid synthesis in this strain.
In L. reuteri CRL 1098, only DMB + CoCl2 and CoCl2 increased
vitamin B12 production while the other intermediaries evaluated
(L-Thr, ALA, PBG, and UIII) had no positive effect.
Purification, Quantification, and
Characterization of the Corrinoid
Compounds Produced by Lactobacillus
Strains
Bioassay and immunoassay demonstrated that both CoCl2 and
DMB + CoCl2 addition increased the production of corrinoid
compound by L. coryniformis CRL 1001 and L. reuteri CRL 1098;
while the presence of L-Thr + CoCl2 induced the corrinoid
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FIGURE 2 | cbi-cob-hem gene clusters comparison between L. coryniformis CRL 1001 and L. reuteri CRL 1098. Arrows indicate the transcription direction depict
genes. Orthologous conserved genes are depicted as gray and black bars.
FIGURE 3 | Relative quantification of corrinoid compounds produced by
L. reuteri CRL 1098 and L. coryniformis CRL 1001 with addition of different
intermediaries. Results are presented as 1B12 (net difference of the corrinoid
quantification with [B12 int.] and without intermediary [B12basal]). ALA
(5-aminolevulinic acid), PBG (Porphobilinogen), UIII (Uroporphyrinogen III),
CoCl2 (Cobalt, Co+), L-Thr (L-threonine) + CoCl2, DMB
(5,6-dimethylbenzimidazole) + CoCl2.
production only in CRL 1001 strain. L-Thr was not evaluated
in further assays for CRL 1098 strain as it had no effect on
the corrinoid formation. To evaluate the optimum cobalamin
production of CRL 1001 strain, a set of different growth
conditions were evaluated (i) CoCl2, (ii) CoCl2 + DMB, and
(iii) CoCl2 + L-Thr. In subsequent experiments, the corrinoid
production by L. reuteri CRL 1098 was evaluated only in the
presence of CoCl2 and CoCl2 + DMB. In order to purify the
corrinoid compounds, the peaks with retention time (RT) close
to cyanocobalamin (CN-Cbl) RT (24.98 min) were collected
(Figure 4) and analyzed for cobalamin activity by bioassay
using S. Typhimurium AR 2680 as indicator strain. All the
collected peaks showed the same B12 complementation ability
than CN-Cbl standard (data not shown). Furthermore, higher
corrinoid levels with DMB + CoCl2 addition compared with
the basal condition (CoCl2 alone) were obtained. The corrinoid
production in the presence of DMB was twofold and 2.2-
fold greater for CRL 1098 and CRL 1001 strains, respectively,
compared to the basal condition. The L-Thr + CoCl2 addition
to the medium increased by 2.6-fold the corrinoid synthesis
in L. coryniformis CRL 1001 respect to the basal condition
(Table 2).
To characterize the corrinoid compounds, liquid
chromatography–electrospray ionization/tandem mass
spectrometry (LC/ESI–MS/MS) to the collected peaks was
performed. Transitions were sought in the MS and MS/MS
spectra of the peaks with cobalamin activity. The transitions
678.3 (m/z) [M + 2H+]++ to 358.7 (m/z) and 678.3 (m/z)
[M + 2H+]++ to 146.9 (m/z) were examined for corrinoid
compounds where DMB is the aglycon attached to ribofuranose
3-phosphate. For corrinoid compounds where adenine is the
aglycon attached to ribofuranose 3-phosphate, transitions
672.5 (m/z) [M + 2H+]++ to 347.8 (m/z) and 672.5 (m/z)
[M + 2H+]++ to 135.9 (m/z) were sought. For all active
peaks analyzed, the MS spectra indicated that a double charged
ion with an approximately m/z of 673 [M + 2H+]++ was
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FIGURE 4 | RP-HPLC chromatogram of the cell extract (CE) from L. reuteri CRL 1098 (A CoCl2 B DMB + CoCl2) and L. coryniformis CRL 1001 (C- CoCl2 D-
DMB + CoCl2 E- L-Thr + CoCl2). An arrow indicates peaks corresponding to the corrinoid compound.
prominent. The MS/MS spectrum showed that the dominant
ions with a value approximate m/z 347.8 [M + 2H+]++
were attributable to Coα-[α-(7-adenyl)]-Coβ-cyanocobamide
(Pseudo B12). In this compound type, adenine is the aglycon
attached to ribofuranose-3-phosphate in the lower ligand
(Figure 5).
Expression of Key Genes of the
Corrinoid Biosynthesis Pathway
Since the addition of biosynthetic intermediaries improved
cobalamin production in both strains, the relative expression
of key genes of the biosynthetic pathway in cells grown
during 3 h (lag phase), 6 h (exponential phase), and 9 h
(late-exponential phase) in B12 free medium in the presence
of different intermediaries was tested by qPCR. The time of
incubation (3, 6, and 9 h) in the B12 free medium with CoCl2
was the condition used as reference, to which the arbitrary value
of 1 was assigned for both strains. Basal level of expression
of key genes in the vitamin B12 free medium with different
intermediaries was observed for both strains at all growth phases.
The relative expression levels of the key genes with DMB and
L-Thr addition remained unchanged in the strains under study
after 3, 6, and 9 h of incubation with respect to the basal
condition (data not shown). These data demonstrate that the key
genes studied for L. reuteri CRL 1098 and L. coryniformis CRL
1001 may be regulated at a post-transcriptional or translational
level.
TABLE 2 | Corrinoid compounds quantification by HPLC.
L. reuteri CRL 1098 Intermediaries Corrinoid (µg/mL)#
CoCl2 1.28 ± 0.26∗
DMB + CoCl2 2.52 ± 0.20
L. coryniformis CRL 1001 Intermediaries Corrinoid (µg/mL)
CoCl2 1.34 ± 0.18
DMB + CoCl2 2.98 ± 0.43
L-Thr + CoCl2 3.45 ± 0.48
The corrinoid concentration in CEs was calculated with a commercial CN-Cbl
standard curve and the active peaks areas. #Corrinoid concentration in CEs was
calculated with a commercial CN-Cbl standard curve and the active peaks areas.
∗Standard deviation.
DISCUSSION
We have previously reported that L. reuteri CRL 1098
supplementation efficiently correct the nutritional vitamin B12
deficiency in an in vivo model (Molina et al., 2008, 2009). In this
work, cobalamin biosynthesis intermediaries were added to the
vitamin B12 free medium to analyse their effect on the corrinoid
production by two different Lactobacillus strains.
The common precursor of all tetrapyrrole molecules
(cobalamin, heme, and chlorophyll) is ALA. The result of two
condensed ALA molecules is PBG. Finally, four PBG molecules
are polymerized and cyclized to form UIII, the last common
intermediary (Kang et al., 2012). Mohammed et al. (2014)
reported an increase in vitamin B12 production by Bacillus
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FIGURE 5 | Liquid chromatography–electrospray ionization/tandem-mass spectrometry (LC/ESI–MS/MS) chromatograms of peaks with cobalamin activity. The
transitions are shown together (SRMs, 672.5 m/z – > 136.0 m/z calculated for adenine y 672.5 m/z – > 348.0 m/z correspond to the lower ligand in which adenine
is the aglycon attached to ribofuranose 3-phosphate). Total ion chromatogram (TIC) of the active peaks of L. reuteri CRL 1098 (A- CoCl2 B- DMB + CoCl2) and
L. coryniformis CRL 1001 (C- CoCl2 D- DMB + CoCl2 E- L-Thr + CoCl2).
(B.) megaterium with addition of ALA to the culture medium
(Mohammed et al., 2014). Different results were obtained for
both L. reuteri CRL 1098 and L. coryniformis CRL 1001 strains, in
which the decreased corrinoid compound production with ALA,
PBG, and UIII addition may be due to a negative regulation by a
classical feedback control (Robin et al., 1991).
Regarding CoCl2 and DMB addition, an increased cobalamin
production is described for Propionibacterium and Bacillus
strains (Mohammed et al., 2014; Wang et al., 2015). Similar
results are reported for both Lactobacillus strains, CRL1001 and
CRL1098, in the present study.
In the anaerobic pathway of the cobalamin biosynthesis,
precorrin-2 is chelated with cobalt a reaction that is catalyzed
by CbiK enzyme. Cobalt requirements for cobalamin-
type corrinoids synthesis is proposed as screening criteria
for detecting producer strains of Propionibacterium and
Lactobacillus genera (Seidametova et al., 2004; Bhushan et al.,
2016). In this work, we report that cobalt addition as chloride salt
allowed the growth of both CRL 1098 and CRL 1001 Lactobacillus
strain. Moreover, the cobalt addition also increased the corrinoid
production in both strains compared with our previous data
without cobalt addition (Taranto et al., 2003; Torres et al.,
2016).
In another step of the biosynthesis, DMB is the nucleotide
attached to the aminopropanol arm as lower ligand in the
cobalamin molecule (Hazra et al., 2015). The cobalamin-type
corrinoid compounds produced by CRL 1001 and CRL 1098
strains increased with DMB addition. Nevertheless, LC-MS
results were different as expected since the molecules synthesized
corresponded to pseudo-B12 despite the positive regulation
on the synthesis. This compound, with adenine instead of
DMB as lower ligand base is synthesized in most bacteria
able to produce cobalamin-type corrinoid compounds via the
anaerobic pathway (Taga and Walker, 2008). Hazra et al. (2013)
proposed that CobT enzyme of L. reuteri CRL 1098 expressed
in E. coli activates DMB rather than other molecules as base
of the lower ligand (Hazra et al., 2013). According to our
results, CRL 1098 strain is not able to use DMB instead of
adenine for vitamin B12 synthesis. As previously published,
L. coryniformis CRL 1001 does not have the cobT gene but
the genes encoding CblS (a kinase enzyme) and CblT (a
transporter protein) (Torres et al., 2016). Mattes and Escalante-
Semerena (2017) observed that cblST genes of Geobacillus
(G.) kaustophilus expressed in S. enterica 1cobT that CblT
transports DMB into the cell and CblS activate preferably
ribazole over adenine (Mattes and Escalante-Semerena, 2017).
Our results are not in agreement with this statement since
pseudo-B12 is obtained, thus suggesting that CblS is unable to
phosphorylate DMB despite entering the cell. Further studies
are oncoming in both strains for a better understanding of
the changes taking place in the lower ligand nucleotide of the
molecule.
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In a different way to the previously described, the L-Thr
addition to the vitamin B12 free medium showed different results
in L. reuteri CRL 1098 and L. coryniformis CRL 1001 strains. The
increased production of cobalamin-type corrinoid compounds in
CRL 1001 strain could be ascribed to the presence of pduX gene
in the genome (Torres et al., 2016). The pduX encodes a protein
kinase able to phosphorylate free L-Thr prior to the formation of
lower ligand aminopropanol arm (Fan and Bobik, 2008). For this
reason, we propose that L-Thr may exert some positive regulation
in the synthesis of this type of compounds.
The study of the expression profile of key genes encoding
proteins involved in cobalamin-type corrinoid compound
synthesis showed no expression change despite the increased
cobalamin production in both strains. Data obtained by different
work groups showed that cobalamin synthesis is regulated by a
riboswitch mechanism (Nahvi et al., 2004). Briefly, binding of
cobalamin to the cob mRNA inhibits the initiation of translation
and stabilizes the complex formed between them (Polaski et al.,
2016). For these reasons, we suggest that the regulation is at
the post-transcriptional or translational level. Our results are in
agreement with previous reports since no changes in regulation
of key synthesis genes of the mRNA transcription phase were
evidenced (Nahvi et al., 2004).
In this study, we demonstrate that addition of key
intermediaries to the vitamin B12 free medium increases the
corrinoid production by both CRL1001 and CRL 1098 lactobacilli
strains. In addition, the existence of two different cobalamin-
type corrinoid compound biosynthetic pathways in two close
phylogenetic strains was confirmed. The results obtained in this
study would improve the production of these cobalamin-type
corrinoid compounds by the food grade L. coryniformis CRL
1001 and L. reuteri CRL 1098 strains.
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